Leerink partners, TD Cowen, and William Blair initiated coverage and set ratings for Kailera Therapeutics.

The entities involved

• TD Cowen →

  American investment bank

  • Cantor Fitzgerald raised price targets and reaffirmed ratings, while TD Cowen adjusted its ratings for Paylocity on August 7, 2026.Mon 23:14
  • TD Cowen reaffirmed a Buy rating for Chipotle Mexican Grill stock.Mon 23:06
• Leerink partners →

  U.S. investment bank

  • Kazia Therapeutics Limited is seeking joint bookrunning management and co-management for a proposed offering, with Leerink partners and Needham & Company involved.Thu 14:48
  • Leerink Partners is acting as a placement agent for First Tracks Biotherapeutics.Thu 14:29

Related events

• Leerink Partners started coverage on Nautilus Biotechnology on October 6, 2026.Oct 7
• Citigroup reissued a market outperform rating and Leerink Partners began coverage on Rapport Therapeutics.Oct 9
• TD Cowen initiated coverage on Northern Trust shares on October 8, 2026.Oct 8
• TD Cowen initiated coverage on Citizens Financial Group shares.Oct 8
• TD Cowen reiterated a buy rating on MBX Biosciences shares, and Citigroup restated an outperform rating on the company.Jun 29